Breast Cancer Risk and Risk Assessment Models Jessica Ray, MS, CGC

Cancer Genetic Counselor Ambry Genetic Laboratories [email protected]

¡Vida! Educational Series - Promoting Good Health

Learning Objectives

• • • Identify Personal and Family Characteristics that may indicate an inherited increased risk for cancer Understand the role of genetic counseling in assessing patients with possible hereditary cancer syndromes Understand characteristics, advantages, limitations, and differences of the Gail and BRCAPRO risk-assessment tools used by clinicians to help establish cancer risk

Who Is at “High Risk”?

• • • • • • Atypia 5-year Gail risk >1.7% 2 or more 2nd-degree premenopausal affected relatives Combined estrogen-progesterone hormone therapy for more than 10 years Mammographically dense breasts Obesity

Who Is at “Very High Risk”?

• • • • • Personal history of BC <50 BRCA1 or BRCA2 mutation carrier 2 or more 1st-degree relatives with BC Lobular carcinoma in situ (LCIS) Atypia and a 1st-degree relative with BC

What is Genetic Counseling?

Genetic Counseling

associated with the disorder in a family is a communication process that deals with both the medical and psychological issues occurrence of a genetic • Cancer genetic counseling focuses on hereditary cancer syndromes • This process involves one or more trained professionals to help the individual or family

• • • •

Reasons for Seeking Genetics Consultation

To learn about • Personal risk for cancer • • • Children’s risk for cancer Family’s risk for cancer Risks for developing cancer if you have a “cancer gene” Recommendations for screening, surveillance, and/or treatment Educational information To obtain genetic DNA testing J Med Genet 2000; 37:866-874

Key Flags that Warrant Genetic Counseling

• • • • • • • Significant family medical history-breast, ovarian, prostate, colon, uterine, melanoma, pancreatic, or other cancers Cancer occurs in every generation Early age of onset (< 50 years) Male breast cancer Bilateral cancer, or multiple primary cancers in one individual Known family genetic mutation Ethnicity – Ashkenazi Jewish ancestry

Sporadic, Familial or Hereditary?

• • • • •

5-10%

cancers have a hereditary component Over

200

hereditary cancer syndromes described Hereditary cancer tends to occur at younger ages than sporadic cancer, often bilateral, multifocal Lifetime risks of cancer

exceed

cancer risks due to noninherited factors (early menarche, nulliparity, late age of menopause, HRT, etc) Majority show an

autosomal dominant

pattern (few are recessive) inheritance

Average Age of Diagnosis Hereditary Sporadic

• • •

Breast Prostate 41 Ovarian 40-50 63

•

Breast

•

Ovarian

•

Prostate 62 60 71

Gail Model

National Cancer Institute http://www.cancer.gov/bcrisktool/Default.aspx

Gail Model: Advantages

• • • • • Identifies women who could benefit from preventive interventions; may assist in making clinical decisions (Determination of eligibility for tamoxifen for breast cancer risk reduction…Gail score>1.7) Incorporates risk factors other than family history (eg, reproductive variables, atypical hyperplasia, history of breast biopsies) Calculation of breast cancer risk in absence of family history in women Shows that BC risk increases with age and, therefore, may prompt discussion about the importance of BC screening Used to counsel and educate women, especially those who overestimate their BC risk

Gail Model: Limitations

• • • • • • Not validated for black, Hispanic, and other ethnic groups Only solicits family history involving first-degree relatives May underestimate risk when family history is on father’s side Does not take into account age at which relatives developed BC Effect of number of breast biopsies (without atypical hyperplasia) may cause inflated risk estimates May underestimate risk for women with demonstrated mutations of the BRCA1 or BRCA2 genes

BRCAPRO - Advantages

• • • • • Incorporates both affected and unaffected family members in estimation of carrier probability incorporates maternal and paternal breast and ovarian cancer history age at cancer diagnosis, current ages, ages relatives became deceased considered Ashkenazi Jewish ethnicity taken into consideration Oophorectomy status and breast cancer receptor status considered

BRCAPRO - Limitations

• Dependent on published estimates of prevalence and penetrance of BRCA1 and BRCA2 • Does not consider more distant family history past 1 st and 2 nd degree relatives • Does not consider other potential susceptibility genes with features similar to BRCA1 and BRCA2

•

When Do You Offer Testing?

American Society of Clinical Oncology

recommends genetic testing : • The individual has a personal or family history of features suggestive of a genetic cancer susceptibility condition • • The test can be adequately interpreted The results will aid in diagnosis or influence the medical or surgical management of the patient or family members at hereditary risk of cancer • •

ASCO

recommendations: Genetic testing only be done in the setting of pre-and post-test counseling, Should discuss possible risks and benefits of cancer early detection and prevention modalities

Implications/Important Points

• • • • • What do we offer individuals at high risk for hereditary cancers who test negative for a genetic mutation?

Negative genetic test result does not mean No Increased Risk!!

AZCC High Risk Clinic for individuals at greater risk of developing cancer Must continue studies to find other genes responsible for hereditary cancers Must develop more advanced, individualized risk assessment tools